A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation (original) (raw)
McKeithan TW, Takimoto GS, Ohno H, Bjorling VS, Morgan R, Hecht BK et al. BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study. Genes Chromosomes Cancer 1997; 20: 64–72. ArticleCASPubMed Google Scholar
Michaux L, Dierlamm J, Wlodarska I, Bours V, Van den Berghe H, Hagemeijer A . t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases. Cancer Genet Cytogenet 1997; 94: 36–43. ArticleCASPubMed Google Scholar
Ueshima Y, Bird ML, Vardiman JW, Rowley JD . A 14;19 translocation in B-cell chronic lymphocytic leukemia: a new recurring chromosome aberration. Int J Cancer 1985; 36: 287–290. ArticleCASPubMed Google Scholar
Rayet B, Gelinas C . Aberrant rel/nfkb genes and activity in human cancer. Oncogene 1999; 18: 6938–6947. ArticleCASPubMed Google Scholar
McKeithan TW, Rowley JD, Shows TB, Diaz MO . Cloning of the chromosome translocation breakpoint junction of the t(14;19) in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1987; 84: 9257–9260. ArticleCASPubMedPubMed Central Google Scholar
Ohno H, Takimoto G, McKeithan TW . The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 1990; 60: 991–997. ArticleCASPubMed Google Scholar
McDonnell TJ, Korsmeyer SJ . Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991; 349: 254–256. ArticleCASPubMed Google Scholar
Ong ST, Hackbarth ML, Degenstein LC, Baunoch DA, Anastasi J, McKeithan TW . Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice. Oncogene 1998; 16: 2333–2343. ArticleCASPubMed Google Scholar
Siebert R, Rosenwald A, Staudt LM, Morris SW . Molecular features of B-cell lymphoma. Curr Opin Oncol 2001; 13: 316–324. ArticleCASPubMed Google Scholar
Willis TG, Dyer MJ . The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 2000; 96: 808–822. CASPubMed Google Scholar
Soma LA, Gollin SM, Remstein ED, Ketterling RP, Flynn HC, Rajasenan KK et al. Splenic small B-cell lymphoma with IGH/BCL3 translocation. Hum Pathol 2006; 37: 218–230. ArticleCASPubMed Google Scholar
Huh YO, Abruzzo LV, Rassidakis GZ, Parry-Jones N, Schlette E, Brito-Bapabulle V et al. The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases. Br J Haematol 2007; 136: 220–228. ArticleCASPubMed Google Scholar
Au WY, Horsman DE, Ohno H, Klasa RJ, Gascoyne RD . Bcl-3/IgH translocation (14;19)(q32;q13) in non-Hodgkin's lymphomas. Leuk Lymphoma 2002; 43: 813–816. ArticleCASPubMed Google Scholar
Martin-Subero JI, Wlodarska I, Bastard C, Picquenot JM, Hoppner J, Giefing M et al. Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma. Blood 2006; 108: 401–402, author reply 402–403. ArticleCASPubMed Google Scholar
Michaux L, Mecucci C, Stul M, Wlodarska I, Hernandez JM, Meeus P et al. BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders. Genes Chromosomes Cancer 1996; 15: 38–47. ArticleCASPubMed Google Scholar
Sole F, Woessner S, Florensa L, Perez-Losada A, Bonet C, Besses C . A new case of t(14;19) (q32;q13) in a patient with follicular lymphoma in leukemic phase. Cancer Genet Cytogenet 1994; 75: 72–73. ArticleCASPubMed Google Scholar
van Krieken JH, McKeithan TW, Raghoebier S, Medeiros LJ, Kluin PM, Raffeld M . Chromosomal translocation t(14;19) as indicated by bcl-3 rearrangement is a rare phenomenon in non-Hodgkin's lymphoma and chronic lymphocytic leukemia: a molecular genetic analysis of 176 cases. Leukemia 1990; 4: 811–812. CASPubMed Google Scholar
Baro C, Salido M, Domingo A, Granada I, Colomo L, Serrano S et al. Translocation t(9;14)(p13;q32) in cases of splenic marginal zone lymphoma. Haematologica 2006; 91: 1289–1291. PubMed Google Scholar
Yamamoto K, Nakamura Y, Arai H, Aoyagi M, Saito K, Furusawa S et al. Translocation (14;19)(q32;q13) detected by spectral karyotyping and lack of BCL3 rearrangement in CD5-positive B-cell lymphoma associated with hemophagocytic syndrome. Cancer Genet Cytogenet 2001; 130: 38–41. ArticleCASPubMed Google Scholar
Sonoki T, Harder L, Horsman DE, Karran L, Taniguchi I, Willis TG et al. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood 2001; 98: 2837–2844. ArticleCASPubMed Google Scholar
Martin-Subero JI, Harder L, Gesk S, Schlegelberger B, Grote W, Martinez-Climent JA et al. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci. Int J Cancer 2002; 98: 470–474. ArticleCASPubMed Google Scholar
Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL et al. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 2001; 98: 3413–3420. ArticleCASPubMed Google Scholar
Küppers R, Sonoki T, Satterwhite E, Gesk S, Harder L, Oscier DG et al. Lack of somatic hypermutation of IG V(H) genes in lymphoid malignancies with t(2;14)(p13;q32) translocation involving the BCL11A gene. Leukemia 2002; 16: 937–939. ArticlePubMed Google Scholar
Ritgen M, Lange A, Stilgenbauer S, Dohner H, Bretscher C, Bosse H et al. Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia. Blood 2003; 101: 2049–2053. ArticleCASPubMed Google Scholar
Saez B, Martin-Subero JI, Guillen-Grima F, Odero MD, Prosper F, Cigudosa JC et al. Chromosomal abnormalities clustering in multiple myeloma reveals cytogenetic subgroups with nonrandom acquisition of chromosomal changes. Leukemia 2004; 18: 654–657. ArticleCASPubMed Google Scholar
Matutes E, Oscier D, Garcia-Marco J, Ellis J, Copplestone A, Gillingham R et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996; 92: 382–388. ArticleCASPubMed Google Scholar
Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK . Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854. CASPubMed Google Scholar
Davis ZA, Orchard JA, Corcoran MM, Oscier DG . Divergence from the germ-line sequence in unmutated chronic lymphocytic leukemia is due to somatic mutation rather than polymorphisms. Blood 2003; 102: 3075. ArticleCASPubMed Google Scholar
Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stilgenbauer S, Stevenson F et al. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia 2007; 21: 1–3. ArticleCASPubMed Google Scholar
Harris NL, Jaffe ES, Vardiman JW, Stein H, Diebold J, M-HH K et al. WHO classification of tumors of haematopoietic and lymphoid tissue: Introduction. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumors Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001, 12–13. Google Scholar
Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354: 2419–2430. ArticleCASPubMed Google Scholar
Bloomfield CD, Arthur DC, Frizzera G, Levine EG, Peterson BA, Gajl-Peczalska KJ . Nonrandom chromosome abnormalities in lymphoma. Cancer Res 1983; 43: 2975–2984. CASPubMed Google Scholar
Canoz O, Rassidakis GZ, Admirand JH, Medeiros LJ . Immunohistochemical detection of BCL-3 in lymphoid neoplasms: a survey of 353 cases. Mod Pathol 2004; 17: 911–917. ArticlePubMed Google Scholar
Mathas S, Johrens K, Joos S, Lietz A, Hummel F, Janz M et al. Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas. Blood 2005; 106: 4287–4293. ArticleCASPubMed Google Scholar
Akasaka T, Ueda C, Kurata M, Akasaka H, Yamabe H, Uchiyama T et al. Nonimmunoglobulin (non-Ig)/BCL6 gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6. Blood 2000; 96: 2907–2909. CASPubMed Google Scholar
Bertrand P, Maisonneuve C, Maingonnat C, M.N. C, J.M. P, Tilly H et al. Preliminary study of c-MYC rearrangements with non-IG partners in B-cell lymphomas. Ann Oncol 2005; 16: v80. Google Scholar
Dunphy CH, van Deventer HW, Carder KJ, Rao KW, Dent GA . Mature B-cell acute lymphoblastic leukemia with associated translocations (14;18)(q32;q21) and (8;9)(q24;p13). A Burkitt variant? Arch Pathol Lab Med 2003; 127: 610–613. PubMed Google Scholar
Chapiro E, Russell L, Radford-Weiss I, Bastard C, Lessard M, Struski S et al. Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. Blood 2006; 108: 3560–3563. ArticleCASPubMed Google Scholar
Akasaka T, Balasas T, Russell LJ, Sugimoto KJ, Majid A, Walewska R et al. Five members of the CEBP transcription factor family are targeted by recurrent IGH-translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 2007; 109: 3451–3461. ArticleCASPubMed Google Scholar
Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW . Immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B-cell lymphoma. J Exp Med 2007; 204: 633–643. ArticleCASPubMedPubMed Central Google Scholar
Schlette E, Rassidakis GZ, Canoz O, Medeiros LJ . Expression of bcl-3 in chronic lymphocytic leukemia correlates with trisomy 12 and abnormalities of chromosome 19. Am J Clin Pathol 2005; 123: 465–471. ArticlePubMed Google Scholar
Oscier DG, Gardiner A, Mould S . Structural abnormalities of chromosome 7q in chronic lymphoproliferative disorders. Cancer Genet Cytogenet 1996; 92: 24–27. ArticleCASPubMed Google Scholar
Boonstra R, Bosga-Bouwer A, van Imhoff GW, Krause V, Palmer M, Coupland RW et al. Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32. Mod Pathol 2003; 16: 1210–1217. ArticlePubMed Google Scholar
Stokke T, DeAngelis P, Smedshammer L, Galteland E, Steen HB, Smeland EB et al. Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma. Br J Cancer 2001; 85: 1900–1913. ArticleCASPubMedPubMed Central Google Scholar
Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A et al. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 1994; 84: 1043–1049. CASPubMed Google Scholar
Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916. ArticleCASPubMed Google Scholar
Vasconcelos Y, Davi F, Levy V, Oppezzo P, Magnac C, Michel A et al. Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia. J Clin Oncol 2003; 21: 3928–3932. ArticleCASPubMed Google Scholar
Ghiotto F, Fais F, Valetto A, Albesiano E, Hashimoto S, Dono M et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest 2004; 113: 1008–1016. ArticleCASPubMedPubMed Central Google Scholar
Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood 2007; 109: 259–270. ArticleCASPubMed Google Scholar